Lisa Wang, MD
Internal Medicine · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wang’s office at (650) 934-7808 to ask if they take your plan before you enroll.
California Medical Board record
Licence A163574 · Delinquent
Licence status: Delinquent · since 2019 · expires 2023-07-31 · Robert Larner, M.D. College of Medicine at the University of Vermont.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$2,456
Pharmacies billed $2,456 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 60) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
55 generic and fewer than 11 brand-name prescriptions · $2,456 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 60 | 18 | 0% (0) | None | $2,456 |
| 2023 | 295 | 70 | None | None | $29,498 |
| 2022 | 304 | 96 | 5% (15) | None | $16,081 |
| 2021 | 103 | 32 | 0% (0) | 17% | $12,085 |
| 2020 | 76 | 36 | 0% (0) | 17% | $5,143 |
| 2019 | 88 | 38 | 0% (0) | None | $3,728 |
| 2018 | 23 | 11 | 0% (0) | None | $793 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 23 | $23,085 | $1,004 |
| Atorvastatin | 25 | $338 | $14 |
| Levothyroxine | 23 | $265 | $12 |
| Losartan | 13 | $141 | $11 |
| Hydrochlorothiazide | 14 | $100 | $7 |
| Amlodipine Besylate | 13 | $53 | $4 |
2022: 6 drugs
| Levothyroxine | 21 | $432 | $21 |
| Atorvastatin | 17 | $115 | $7 |
| Hydrochlorothiazide | 17 | $114 | $7 |
| Losartan | 12 | $101 | $8 |
| Simvastatin | 14 | $85 | $6 |
| Lisinopril | 15 | $43 | $3 |
Money from drug and device companies
$35 in 2024
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Zepzelca | $35 | 1 payment
|
See the published payment
| Jazz Pharmaceuticals | Meals · 2024-07-18 | Zepzelca | $35 |
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Veru Inc. · Veru001 V2000701 80052317 · 2023 | Their institution | $11,572 |
| Veru Inc. · Veru001 V2000701 80052317 · 2024 | Their institution | $4,903 |
Professional record
- NPI
- 1306340989
- Licence
- CA A163574California A163574: Delinquent · expires 2023-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-03-20
- NPI last updated
- 2021-11-09
- NPI record certified
- 2021-11-09
This is when the NPI record was last certified, not a medical board exam.